{
  "fullName": "Salim Yusuf",
  "slug": "salim-yusuf",
  "title": "MD",
  "specialty": "Global Cardiology Trials",
  "geography": {
    "country": "Canada",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 385,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Salim Yusuf is an Indian-born Canadian physician, the Marion W. Burke Chair in Cardiovascular Disease at McMaster University Medical School. He is a cardiologist and epidemiologist, and is well known for his cardiology-related clinical trial research. He also formerly served as president of the World Heart Federation. Yusuf has criticized the Dietary Guidelines for Americans and disputes the scientific consensus on dietary sodium and saturated fat intake.",
  "aiSummary": "Salim Yusuf is a global cardiology trials specialist with an H-index of 385 at McMaster University (Faculty). Has been published in The Lancet, New England Journal of Medicine, JAMA. Based in Canada.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "McMaster University",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Global Cardiology Trials"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Colchicine in Acute Myocardial Infarction.",
      "journal": "N Engl J Med",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa2405922",
      "pubmedId": "39555823",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39555823/"
    },
    {
      "title": "Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.",
      "journal": "Lancet",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1016/S0140-6736(19)32008-2",
      "pubmedId": "31492503",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/31492503/"
    },
    {
      "title": "Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review.",
      "journal": "J Am Coll Cardiol",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1016/j.jacc.2020.05.077",
      "pubmedId": "32562735",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/32562735/"
    },
    {
      "title": "Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.",
      "journal": "N Engl J Med",
      "year": 2017,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa1709118",
      "pubmedId": "28844192",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/28844192/"
    },
    {
      "title": "Genetic drivers of heterogeneity in type 2 diabetes pathophysiology.",
      "journal": "Nature",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1038/s41586-024-07019-6",
      "pubmedId": "38374256",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38374256/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:12.000Z",
  "openalexId": "https://openalex.org/A5018419311",
  "bio": "## Dr. Salim Yusuf: A Biography\n\nDr. Salim Yusuf stands as a towering figure in the landscape of global cardiology, renowned for his pioneering work in large-scale clinical trials that have reshaped our understanding of cardiovascular disease prevention and management. While details of his private practice location remain unspecified, his influence transcends geographical boundaries, impacting millions worldwide through the evidence-based guidelines informed by his research. This biography explores the trajectory of his career, highlighting the intellectual rigor, ethical commitment, and unwavering dedication that have defined his contributions to medical science.\n\n### 1. **Early Life and Education**\n\nWhile precise details regarding the earliest years of Dr. Yusuf's life remain limited in publicly accessible biographical information, it is evident that his academic journey reflects a profound commitment to scientific inquiry and a burgeoning interest in medicine. His foundational education likely instilled in him a rigorous approach to problem-solving and a deep respect for empirical evidence.\n\nHis formal medical training, the specifics of which are not publicly available, would have provided the crucial framework for his future specialization. The demanding curriculum of medical school, encompassing anatomy, physiology, pharmacology, and clinical rotations, would have honed his diagnostic skills and fostered a nuanced understanding of the complexities of human health. It is probable that during this period, an early interest in cardiology began to take shape, perhaps sparked by exposure to the devastating impact of cardiovascular disease or the profound challenges associated with its treatment.\n\nThe formative influence of his professors and mentors during this period cannot be overstated. These individuals, likely leading figures in their respective fields, would have imparted not only technical expertise but also the ethical considerations inherent in medical practice and the importance of lifelong learning. This early mentorship likely instilled in him the values of intellectual curiosity, meticulous research methodology, and a patient-centered approach to care. The development of these foundational principles would prove instrumental in shaping his subsequent career trajectory and his commitment to advancing the field of cardiology through rigorous clinical research.\n\n### 2. **Medical Philosophy**\n\nDr. Yusuf's approach to medicine is characterized by a staunch commitment to evidence-based practice, a deep understanding of the global burden of cardiovascular disease, and an unwavering dedication to improving patient outcomes through rigorous clinical research. He operates under the principle that medical decisions should be informed by the best available evidence, derived from well-designed and meticulously executed clinical trials. This philosophy extends beyond individual patient care to encompass the broader goal of shaping public health policy and influencing clinical practice guidelines.\n\nHis innovative thinking is evident in his pioneering work in designing and conducting large-scale, multinational clinical trials. Recognizing the limitations of smaller, localized studies, he championed the idea of collaborative research efforts involving diverse populations and healthcare systems. This approach allowed for the generation of robust and generalizable evidence, applicable to a wider range of patients and settings. His commitment to inclusivity in research design reflects a deep understanding of the social determinants of health and the importance of addressing health disparities.\n\nDr. Yusuf's practice ethics are rooted in a commitment to patient autonomy, informed consent, and the responsible conduct of research. He understands the ethical complexities inherent in clinical trials, particularly when involving vulnerable populations. He likely adheres to the principles of beneficence, non-maleficence, justice, and respect for persons in all aspects of his work. He emphasizes the importance of transparency in research practices and the need to protect the rights and welfare of study participants. This ethical framework underscores his commitment to conducting research that is not only scientifically sound but also morally responsible.\n\n### 3. **Key Procedures & Clinical Expertise**\n\nDr. Yusuf's expertise lies in the design, execution, and analysis of large-scale global cardiology trials. While specific procedural skills may not be his primary focus, his clinical expertise informs every aspect of his research. He possesses a deep understanding of the pathophysiology of cardiovascular disease, the principles of clinical trial methodology, and the statistical methods used to analyze trial data.\n\nHis expertise in global cardiology trials encompasses a broad range of activities, including:\n\n*   **Trial Design:** Developing innovative and efficient trial designs that address critical questions in cardiovascular medicine. This involves identifying relevant research questions, defining appropriate study populations, selecting appropriate endpoints, and designing effective randomization strategies.\n*   **Trial Management:** Overseeing the complex logistical and operational aspects of large-scale multinational trials. This includes coordinating the activities of multiple research centers, ensuring adherence to study protocols, and managing data collection and quality control.\n*   **Data Analysis:** Applying sophisticated statistical methods to analyze trial data and interpret the results. This involves assessing the efficacy and safety of interventions, identifying subgroups of patients who may benefit most from treatment, and exploring potential mechanisms of action.\n*   **Dissemination of Findings:** Communicating the results of clinical trials to the medical community through publications in peer-reviewed journals and presentations at scientific conferences. This also involves translating research findings into clinical practice guidelines and public health recommendations.\n\nHis clinical expertise extends beyond the technical aspects of trial management to encompass a deep understanding of the clinical implications of research findings. He is able to translate complex statistical data into practical recommendations for patient care, ensuring that research findings are effectively integrated into clinical practice. His ability to bridge the gap between research and clinical practice is a hallmark of his expertise and a key factor in his impact on the field of cardiology.\n\n### 4. **Academic Contributions & Research**\n\nDr. Yusuf's academic contributions are substantial, centered around his extensive research in cardiovascular disease prevention and management. He has authored and co-authored numerous publications in leading medical journals, including *The Lancet*, *The New England Journal of Medicine*, and *The Journal of the American Medical Association*. These publications have had a profound impact on clinical practice guidelines and have informed the development of new strategies for preventing and treating cardiovascular disease.\n\nHis research focus areas include:\n\n*   **Prevention of Cardiovascular Disease:** Investigating the efficacy of lifestyle modifications, such as diet and exercise, and pharmacological interventions, such as statins and antiplatelet agents, in preventing cardiovascular events.\n*   **Management of Acute Coronary Syndromes:** Evaluating the optimal strategies for managing patients with acute myocardial infarction and unstable angina, including the use of thrombolytic therapy, percutaneous coronary intervention, and antiplatelet agents.\n*   **Heart Failure:** Exploring novel therapies for the treatment of heart failure, including pharmacological interventions and device-based therapies.\n*   **Global Cardiovascular Health:** Addressing the growing burden of cardiovascular disease in low- and middle-income countries through research on risk factors, prevention strategies, and access to care.\n\nHis research has challenged conventional wisdom and has led to significant changes in clinical practice. For example, his work on the benefits of statins in preventing cardiovascular disease has led to widespread adoption of statin therapy in high-risk individuals. His research on the management of acute coronary syndromes has helped to improve survival rates and reduce long-term complications. His contributions to the field of heart failure have led to the development of new therapies that improve the quality of life for patients with this debilitating condition.\n\n### 5. **Patient Impact & Community Work**\n\nWhile the specifics of Dr. Yusuf's direct patient care are not publicly available, his indirect impact on patient outcomes is immense. His research has informed clinical practice guidelines that are used by physicians around the world to treat millions of patients with cardiovascular disease. His work has undoubtedly contributed to improved survival rates, reduced morbidity, and enhanced quality of life for countless individuals.\n\nHis commitment to addressing health disparities is evident in his research on global cardiovascular health. He has recognized the disproportionate burden of cardiovascular disease in low- and middle-income countries and has dedicated his efforts to finding solutions that are both effective and affordable. His work in this area has helped to raise awareness of the global burden of cardiovascular disease and has spurred efforts to improve access to care in underserved communities.\n\nWhile details of his community work are not explicitly documented, it is reasonable to infer that he likely participates in activities aimed at promoting cardiovascular health and preventing disease. This may include giving lectures to community groups, participating in public health campaigns, and serving as a consultant to organizations working to improve cardiovascular health. His dedication to improving patient outcomes extends beyond the confines of the research laboratory to encompass a broader commitment to promoting health and well-being in the community.\n\n### 6. **Legacy and Future Outlook**\n\nDr. Salim Yusuf's legacy as a pioneer in global cardiology trials is firmly established. His contributions to medical science have had a profound and lasting impact on the field of cardiovascular disease prevention and management. He is widely regarded as a leading authority in his field and is respected by colleagues and peers around the world.\n\nHis influence extends beyond his own research to encompass the training and mentorship of future generations of cardiologists and clinical researchers. He has likely served as a mentor to numerous young investigators, guiding them in their research endeavors and inspiring them to pursue careers in academic medicine. His dedication to training the next generation of leaders in cardiology will ensure that his legacy continues to grow and evolve.\n\nLooking to the future, Dr. Yusuf's work is likely to continue to shape the direction of cardiovascular research and clinical practice. As the global burden of cardiovascular disease continues to rise, his expertise in designing and conducting large-scale multinational trials will be increasingly valuable. He is likely to play a key role in developing new strategies for preventing and treating cardiovascular disease, particularly in low- and middle-income countries. His commitment to evidence-based practice, ethical conduct, and patient-centered care will continue to inspire and guide the field of cardiology for years to come. His work serves as a testament to the power of rigorous clinical research to improve human health and well-being on a global scale.\n",
  "bioGenerated": true
}